Brief: OSE Immunotherapeutics Provides Updates On Ongoing Court Proceedings
08/09/2025 17:45
Sept 8 (Reuters) - OSE Immunotherapeutics SA OSE.PA: OSE IMMUNOTHERAPEUTICS PROVIDES UPDATE ON ONGOING PROCEEDINGS AHEAD OF SHAREHOLDERS’ ANNUAL GENERAL MEETING OF SEPTEMBER 30, 2025 OSE IMMUNOTHERAPEUTICS SA - COURT HAS TAKEN UNDER ADVISEMENT CONCERTED ACTION BY A GROUP OF MINORITY SHAREHOLDERS OSE IMMUNOTHERAPEUTICS SA: COURT DECISION EXPECTED ON SEPTEMBER 23 Source text: ID:nGNX6bl01L Further company coverage: OSE.PA ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO